Albumin contributes to kidney disease progression in alport syndrome

American Journal of Physiology - Renal Physiology

Volumn 311, Issue 1, 2016, Pages F120-F130

  Jarad, George ^a   Knutsen, Russell H ^a   Mecham, Robert P ^a   Miner, Jeffrey H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Alport syndrome; Collagen type IV

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CHLORDANE; COLLAGEN TYPE 2; COLLAGEN TYPE 3; DESMIN; ENTACTIN; FIBRONECTIN; KIDNEY INJURY MOLECULE 1; LAMININ 1; LAMININ ALPHA2; LAMININ ALPHA5; LAMININ BETA2; NEPHRIN; PODOCIN; SERUM ALBUMIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALBUMINOID; AUTOANTIGEN; COLLAGEN TYPE 4; TYPE IV COLLAGEN ALPHA3 CHAIN;

ALBUMINURIA; ALPORT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION PROCESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DYSLIPIDEMIA; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HYPERTRIGLYCERIDEMIA; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; MOUSE; NEPHROBLASTOMA; NONHUMAN; OUTCOME ASSESSMENT; PODOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; C57BL MOUSE; COMPLICATION; DEFICIENCY; GENETICS; KIDNEY; KIDNEY DISEASES; KNOCKOUT MOUSE; METABOLISM; NEPHRITIS; PATHOLOGY; SURVIVAL ANALYSIS;

ALBUMINS; ANIMALS; AUTOANTIGENS; BLOOD PRESSURE; COLLAGEN TYPE IV; DISEASE PROGRESSION; KIDNEY; KIDNEY DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS, HEREDITARY; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; TRIGLYCERIDES;

EID: 84984596138     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00456.2015     Document Type: Article

References (44)

1. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G. Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomeru-lar passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol 161: 2179–2193, 2002.
2. Abe H, Shibuya T, Odashima S, Arichi S, Nagase S. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats. Nephron 50: 351–355, 1988.
3. Abrahamson DR, Isom K, Roach E, Stroganova L, Zelenchuk A, Miner JH, St John PL. Laminin compensation in collagen α3(IV) knockout (Alport) glomeruli contributes to permeability defects. J Am Soc Nephrol 18: 2465–2472, 2007.
4. Andrews KL, Mudd JL, Li C, Miner JH. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol 160: 721–730, 2002.
5. 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemia. J Clin Invest 38: 863–872, 1959.
6. Buelli S, Abbate M, Morigi M, Moioli D, Zanchi C, Noris M, Zoja C, Pusey CD, Zipfel PF, Remuzzi G. Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. Kidney Int 75: 1050–1059, 2009.
7. Chung JJ, Huber TB, Godel M, Jarad G, Hartleben B, Kwoh C, Keil A, Karpitskiy A, Hu J, Huh CJ, Cella M, Gross RW, Miner JH, Shaw AS. Albumin-associated free fatty acids induce macropinocytosis in podocytes. J Clin Invest 125: 2307–2316, 2015.
8. Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int 71: 615–618, 2007.
9. Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci A, Kalluri R. Integrin α1β1 and transforming growth factor-β1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 157: 1649–1659, 2000.
10. Cybulsky AV. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 77: 187–193, 2009.
11. Cybulsky AV. The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int 84: 25–33, 2012.
12. Davies DJ, Messina A, Thumwood CM, Ryan GB. Glomerular podocytic injury in protein overload proteinuria. Pathology 17: 412–419, 1985.
13. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 296: F118–F126, 2009.
14. Diwakar R, Pearson AL, Colville-Nash P, Brunskill NJ, Dockrell ME. The role played by endocytosis in albumin-induced secretion of TGF-β1 by proximal tubular epithelial cells. Am J Physiol Renal Physiol 292: F1464–F1470, 2007.
15. Eller P, Eller K, Wolf AM, Reinstadler SJ, Tagwerker A, Patsch JR, Mayer G, Rosenkranz AR. Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. Kidney Int 77: 428–435, 2009.
16. Fang L, Xie D, Wu X, Cao H, Su W, Yang J. Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells. PLos One 8: e72344, 2013.
17. Fujihara CK, Limongi DM, De Oliveira HC, Zatz R. Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol Regul Integr Comp Physiol 262: R947–R954, 1992.
18. Fujihara CK, Limongi DM, Falzone R, Graudenz MS, Zatz R. Pathogenesis of glomerular sclerosis in subtotally nephrectomized analbuminemic rats. Am J Physiol Renal Fluid Electrolyte Physiol 261: F256–F264, 1991.
19. Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63: 438–446, 2003.
20. Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, Hocker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dotsch J, Muller-Wiefel DE, Hoyer P, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Muller GA, Weber M. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81: 494–501, 2012.
21. Hathaway CK, Gasim AM, Grant R, Chang AS, Kim HS, Madden VJ, Bagnell CR Jr, Jennette JC, Smithies O, Kakoki M. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice. Proc Natl Acad Sci USA 112: 5815–5820, 2015.
22. Ishola DA Jr, Post JA, van Timmeren MM, Bakker SJ, Goldschmeding R, Koomans HA, Braam B, Joles JA. Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 70: 724–731, 2006.
23. Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities in Lamb2–/– mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 116: 2272–2279, 2006.
24. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280: 32317–32325, 2005.
25. Kashtan CE, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, Rheault M, Licht C. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol 28: 5–11, 2013.
26. Koot BG, Houwen R, Pot DJ, Nauta J. Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. Eur J Pediatr 163: 664–670, 2004.
27. Lemley KV, Kriz W. Glomerular injury in analbuminemic rats after subtotal nephrectomy. Nephron 59: 104–110, 1991.
28. Miner JH, Go G, Cunningham J, Patton BL, Jarad G. Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: implications for Pierson syndrome. Development 133: 967–975, 2006.
29. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of α1–5, identification of heterotrimeric laminins 8–11, and cloning of a novel α3 isoform. J Cell Biol 137: 685–701, 1997.
30. Miner JH, Sanes JR. Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome. J Cell Biol 135: 1403–1413, 1996.
31. Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C, Galbusera M, Gastoldi S, Mundel P, Remuzzi G, Benigni A. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol 166: 1309–1320, 2005.
32. Nagase S, Shimamune K, Shumiya S. Albumin-deficient rat mutant. Science 205: 590–591, 1979.
33. Neuhaus TJ, Stallmach T, Genewein A. A boy with congenital analbuminemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature. Eur J Pediatr 167: 1073–1077, 2008.
34. Ohse T, Inagi R, Tanaka T, Ota T, Miyata T, Kojima I, Ingelfinger JR, Ogawa S, Fujita T, Nangaku M. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int 70: 1447–1455, 2006.
35. Okamura K, Dummer P, Kopp J, Qiu L, Levi M, Faubel S, Blaine J. Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PLos One 8: e54817, 2013.
36. Okuda S, Oochi N, Wakisaka M, Kanai H, Tamaki K, Nagase S, Onoyama K, Fujishima M. Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis. J Lab Clin Med 119: 245–253, 1992.
37. Peired A, Angelotti ML, Ronconi E, la Marca G, Mazzinghi B, Sisti A, Lombardi D, Giocaliere E, Della Bona M, Villanelli F, Parente E, Ballerini L, Sagrinati C, Wanner N, Huber TB, Liapis H, Lazzeri E, Lasagni L, Romagnani P. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol 24: 1756–1768, 2013.
38. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, Gao W, Scholey JW. Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol 16: 1266–1278, 2005.
39. Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D. Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int 56: 1662–1673, 1999.
40. Shalamanova L, McArdle F, Amara AB, Jackson MJ, Rustom R. Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor. Am J Physiol Renal Physiol 292: F1846–F1857, 2007.
41. Wagenseil JE, Knutsen RH, Li DY, Mecham RP. Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture. Am J Physiol Heart Circ Physiol 293: H574–H582, 2007.
42. Yoshida S, Nagase M, Shibata S, Fujita T. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-β and p38 MAPK. Nephron Exp Nephrol 108: e57–68, 2008.
43. Zhao J, Tramontano A, Makker SP. Albumin-stimulated TGFβ-1 in renal tubular cells is associated with activation of MAP kinase. Int Urol Nephrol 39: 1265–1271, 2007.
44. Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, Tian JW. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 76: 1148–1160, 2009.